Study Provides Deep Dive on the Neuroscience of Placebo Effects

Tor Wager, the Diana L. Taylor Distinguished Professor in Neuroscience and co-leader of the Placebo Neuroimaging Consortium discusses a new meta-analysis that gives the most detailed look yet at the neuroscience of placebo effects!  Read more at Dartmouth News

 

fMRI activity during pain is reduced in the areas shown in blue. Many of these are involved in constructing the experience of pain. Activity is increased in the areas shown in red and yellow, which involve the control of cognition and memory. (Image provided by M.Zunhammer et al.)

“Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data”

Abstract

The brain systems underlying placebo analgesia are insufficiently understood. Here weperformed a systematic, participant-level meta-analysis of experimental functional neuroi-maging studies of evoked pain under stimulus-intensity-matched placebo and control con-ditions, encompassing 603 healthy participants from 20 (out of 28 eligible) studies. Wefindthat placebo vs. control treatments induce small, widespread reductions in pain-relatedactivity, particularly in regions belonging to ventral attention (including mid-insula) andsomatomotor networks (including posterior insula). Behavioral placebo analgesia correlateswith reduced pain-related activity in these networks and the thalamus, habenula, mid-cin-gulate, and supplementary motor area. Placebo-associated activity increases occur mainly infrontoparietal regions, with high between-study heterogeneity. We conclude that placebotreatments affect pain-related activity in multiple brain areas, which may reflect changes innociception and/or other affective and decision-making processes surrounding pain.Between-study heterogeneity suggests that placebo analgesia is a multi-faceted phenomenoninvolving multiple cerebral mechanisms that differ across studies.

Access Article Here